Ascendis Pharma Hit By FDA Delay As TransCon CNP Decision Slips To 2026
FDA extends Ascendis' TransCon CNP review to Feb. 28, 2026, after new data submission related to post-marketing study requirements. read more
Benzinga 
These 10 S&P 500 Stocks Are Dirt Cheap This Black Friday
These 10 S&P 500 stocks are trading at the lowest forward P/E ratios heading into Black Friday 2025 — and analysts see major upside ahead. read more
Why Tilray (TLRY) Stock Is Tumbling Friday
Tilray Brands shares are continuing a downward trend after the company confirmed it will implement a 1-for-10 reverse stock split. read more
Boeing Strengthens Defense Orders With Historic Apache Deal
Boeing wins $4.7 billion contract to build 96 AH-64E Apache helicopters for Poland, the largest non-US purchase in the program's history. read more
Emmett Till Center Buys Barn Where Lynching Took Place For $1.5 Million
The move is designed to prevent the site from being exploited by speculators or hate groups, securing the narrative’s integrity for public memory.
Black Enterprise 
Apple and nine more tech companies that have treated their shareholders like gold
The iPhone maker leads the way for the sector in terms of dollars spent on stock buybacks. But other tech companies have reduced their share counts significantly, as well.
MarketWatch 
Ethereum Outpaces Bitcoin, Solana In Speculative Demand — Is A Big Move Coming?
Ethereum (CRYPTO: ETH ) reclaiming the $3,000 level has traders debating whether momentum is building for a continued leg higher, or if the market is setting up for ano read more
Nebius Dropped 30% From Highs — But Its Growth Story Didn't
Nebius stock is 30% below its 52-week high. Its Q3 numbers showed impressive growth, with potential from Avride's autonomous-driving unit. read more
Bitcoin's 'Four-Year Cycle' Isn't Broken — It Was Never Real And The Data Finally Proves It
Bitcoin's (CRYPTO: BTC ) so-called four-y read more
